However, studies have shown that by inducing the expression of death receptor 4 (DR4) and death receptor 5 (DR5) and upregulating TRAIL levels, the sensitivity of CRC cells to TRAIL-induced apoptosis can be enhanced [33,34,35]. Here, TNFRSF10A is linked to colorectal carcinoma.